Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Received: October 16, 2021
Accepted: March 21, 2022
Published online: May 24, 2022

Number of Print Pages: 12
Number of Figures: 2
Number of Tables: 7

ISSN: 0031-7012 (Print)
eISSN: 1423-0313 (Online)

For additional information: https://www.karger.com/PHA

Abstract

Introduction: Sufentanil is used with ropivacaine in labor pain management but it can have respiratory depression. Dexmedetomidine is effective to maintain hemodynamic stability in parturient women and allow awake intubation. However, dexmedetomidine is suggested only in patients with major cardiovascular disease that mandates stable hemodynamics (Reference ID: 3987541-USFDA). The objective of the study was to compare different doses of ropivacaine either with sufentanil or with dexmedetomidine for epidural anesthesia regarding labor pain management. Methods: Parturient women have received 0.125% ropivacaine with 0.5-μg/mL sufentanil (SR1 cohort, n = 115), or 0.08% ropivacaine with 0.5-μg/mL sufentanil (SR2 cohort, n = 109), or 0.125% ropivacaine with 0.5-μg/mL dexmedetomidine (DR1 cohort, n = 124), or 0.08% ropivacaine with 0.5-μg/mL dexmedetomidine (DR2 cohort, n = 135) for epidural anesthesia during vaginal delivery or cesarean section. Results: At 2-h postpartum, the visual analog scale score of parturient women of the DR2 cohort was fewer than that of parturient women of the SR1 (p < 0.0001, q = 4.162) and the SR2 (p < 0.0001, q = 7.568) cohorts and statistically the same as that of parturient women of the DR1 cohort (p < 0.0001, q = 3.087). Bradycardia and itching were reported in parturient women of the DR2 and the DR1 cohorts while nausea, vomiting, and urinary retention at 6 h were reported in parturient women of the SR1 and the SR2 cohorts. In the DR2 cohort, there were fewer numbers of parturient women with bradycardia (4 vs. 19, p < 0.0001, q = 6.613) and hypotension (2% vs. 1%) than those in the DR1 cohort. The child born by women of the DR2 cohort had high partial arterial pressure of oxygen than those born by women of the DR1 (p < 0.0001, q = 18.663), the SR1 (p < 0.0001, q = 29.366), and the SR2 (p < 0.0001, q = 24.039) cohorts. Discussion/Conclusion: Epidural 0.08% ropivacaine with 0.5-μg/mL dexmedetomidine is an effective and safe anesthetic regimen for hypertensive parturient women and their newborns. Level of Evidence: III. Technical Efficacy Stage: 4.

© 2022 S. Karger AG, Basel

References Van de Velde M, Carvalho B. Remifentanil for labor analgesia: an evidence-based narrative review. Int J Obstet Anesth. 2016;25:66–74. Cheng Q, Bi X, Zhang W, Lu Y, Tian H. Dexmedetomidine versus sufentanil with high- or low-concentration ropivacaine for labor epidural analgesia: a randomized trial. J Obstet Gynaecol Res. 2019;45(11):2193–201. He L, Xu JM, Liu SM, Chen ZJ, Li X, Zhu R. Intrathecal dexmedetomidine alleviates shivering during cesarean delivery under spinal anesthesia. Biol Pharm Bull. 2017;40(2):169–73. Ngan Kee WD, Khaw KS, Ng FF, Ng KK, So R, Lee A. Synergistic interaction between fentanyl and bupivacaine given intrathecally for labor analgesia. Anesthesiology. 2014;120(5):1126–36. Wang C, Liu S, Han C, Yu M, Hu Y, Liu C. Effect and placental transfer of dexmedetomidine during caesarean section under epidural anaesthesia. J Int Med Res. 2017;45(3):964–72. Lv BS, Wang W, Wang ZQ, Wang XW, Wang JH, Fang F, et al. Efficacy and safety of local anesthetics bupivacaine, ropivacaine and levobupivacaine in combination with sufentanil in epidural anesthesia for labor and delivery: a meta-analysis. Curr Med Res Opin. 2014;30(11):2279–89. Kulkarni A, Gupta A, Shah SB, Bhargava AK. A comparative study of ropivacaine and bupivacaine with fentanyl for postoperative patient-controlled epidural analgesia after major abdominal oncosurgery. J Curr Oncol. 2018;1(2):66–72. Wang Y, Ma MY, Wang YP, Zhang Y. Application of ropivacaine and levobupivacaine in epidural anesthesia for gynecological surgery. J Reprod Med. 2015 Nov–Dec;60(11–12):491–4. Henderson F, May WJ, Gruber RB, Discala JF, Puskovic V, Young AP, et al. Role of central and peripheral opiate receptors in the effects of fentanyl on analgesia, ventilation and arterial blood-gas chemistry in conscious rats. Respir Physiol Neurobiol. 2014;191:191–5. Yu M, Han C, Jiang X, Wu X, Yu L, Ding Z. Effect and placental transfer of dexmedetomidine during caesarean section under general anaesthesia. Basic Clin Pharmacol Toxicol. 2015;117(3):204–8. Surve RM, Bansal S, Reddy M, Philip M. Use of dexmedetomidine along with local infiltration versus general anesthesia for burr hole and evacuation of chronic subdural hematoma (CSDH). J Neurosurg Anesthesiol. 2017;29(3):274–80. Hospira, Inc. Prescribing information for PrecedexTM; 2015. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/206628s000lbl.pdf (accessed May 27, 2020. Maged AM, Deeb WS, Elbaradie S, Elzayat AR, Metwally AA, Hamed M, et al. Comparison of local and intra venous dexamethasone on post operative pain and recovery after caeseream section: a randomized controlled trial. Taiwan J Obstet Gynecol. 2018;57(3):346–50. Varposhti MR, Ahmadi N, Masoodifar M, Shahshahan Z, Tabatabaie MH. Comparison of remifentanil: entonox with Entonox alone in labor analgesia. Adv Biomed Res. 2013;2(4):87–9. Patel NP, El-Wahab N, Fernando R, Wilson S, Robson SC, Columb MO, et al. Fetal effects of combined spinal-epidural vs epidural labour analgesia: a prospective, randomised double-blind study. Anaesthesia. 2014;69(5):458–67. Zhang T, Yu Y, Zhang W, Zhu J. Comparison of dexmedetomidine and sufentanil as adjuvants to local anesthetic for epidural labor analgesia: a randomized controlled trial. Drug Des Devel Ther. 2019;13:1171–5. Markantonis SL, Melemeni A, Markidou M, Haikali SI, Karalis V, Fassoulaki A. Ropivacaine, interleukin-6 and tumor necrosis factor alpha plasma levels during intermittent epidural and continuous wound infusion of ropivacaine for analgesia after hysterectomy or myomectomy: an observational study. Pharmacology. 2016;98(5–6):294–8. Yan MJ, Wang T, Wu XM, Zhang W. Comparison of dexmedetomidine or sufentanil combined with ropivacaine for epidural analgesia after thoracotomy: a randomized controlled study. J Pain Res. 2019;12:2673–8. Patro SS, Deshmukh H, Ramani YR, Das G. Evaluation of dexmedetomidine as an adjuvant to intrathecal bupivacaine in infraumbilical surgeries. J Clin Diagn Res. 2016;10(3):UC13–6. Qian M, Gao F, Liu J, Xu P. Dexmedetomidine versus fentanyl as adjuvants to ropivacaine for epidural anaesthesia: a systematic review and meta-analysis. Int J Clin Pract. 2021;75(5):e13772. Christiansen CB, Madsen MH, Rothe C, Andreasen AM, Lundstrøm LH, Lange KHW. Volume of ropivacaine 0.2% and common peroneal nerve block duration: a randomised, double-blind cohort trial in healthy volunteers. Anaesthesia. 2018;73(11):1361–7. Xu A, Matushewski B, Cao M, Hammond R, Frasch MG, Richardson BS. The ovine fetal and placental inflammatory response to umbilical cord occlusions with worsening acidosis. Reprod Sci. 2015;22(11):1409–20. Wangping Z, Ming R. Optimal dose of epidural dexmedetomidine added to ropivacaine for epidural labor analgesia: a pilot study. Evid Based Complement Alternat Med. 2017;2017:7924148. ASA House of Delegates/Executive Committee. ASA physical status classification system; 2020. Available from: https://www.asahq.org/standards-and-guidelines/asa-physical-status-classification-system. Zhang W, Li C. EC50 of epidural ropivacaine combined with dexmedetomidine for labor analgesia. Clin J Pain. 2018;34(10):950–3. Article / Publication Details

First-Page Preview

Received: October 16, 2021
Accepted: March 21, 2022
Published online: May 24, 2022

Number of Print Pages: 12
Number of Figures: 2
Number of Tables: 7

ISSN: 0031-7012 (Print)
eISSN: 1423-0313 (Online)

For additional information: https://www.karger.com/PHA